Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma recurrence rates and patterns did not differ between patients who underwent ...

Please provide your email address to receive an email when new articles are posted on . Patients with complete response to hepatocellular carcinoma and underwent direct-acting antiviral therapy for ...

According to data from eight studies being presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, there remains continued debate on whether patients are at risk of ...

Recurrence of hepatocellular carcinoma after resection or ablation with curative intent is common and not prevented by direct-acting antiviral agent (DAA) therapy for hepatitis C. Owing to multiple ...